Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination

Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination

Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...

Bibliografske podrobnosti
Main Authors:	Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL
Format:	Journal article
Izdano:	Frontiers Media 2017

Podobne knjige/članki

Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
od: Fatoumatta Darboe, et al.
Izdano: (2017-09-01)

Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
od: Ng, K.L., et al.
Izdano: (2017)

Bacillus Calmette–Guérin Immunotherapy for Cancer
od: Fabíola Cardillo, et al.
Izdano: (2021-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
od: Azad H.A. Razack
Izdano: (2007-10-01)

Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
od: Markus U Göttke, et al.
Izdano: (2000-01-01)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
od: Dayoung Ko, et al.
Izdano: (2022-04-01)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
od: Ewa Anna Bernatowska, et al.
Izdano: (2007-05-01)

Breast abscess due to Bacillus Calmette-Guérin
od: Aurélien Dinh, et al.
Izdano: (2017-06-01)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
od: Oluwafolajimi A. Adesanya, et al.
Izdano: (2021-02-01)

Is it time to rethink maintenance Bacillus Calmette-Guerin?
od: Vivek Venkatramani
Izdano: (2012-01-01)

Bacillus Calmette-Guerin in the management of superficial bladder cancer
od: Rakesh Kapoor, et al.
Izdano: (2008-01-01)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
od: Benjamin Y. Klein, et al.
Izdano: (2022-06-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
od: Sung-Hsi Wei, et al.
Izdano: (2018-04-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
od: Rolandas Selvestravičius, et al.
Izdano: (2016-09-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
od: Mohammad Alghafees, et al.
Izdano: (2025-01-01)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
od: Yun Peng, et al.
Izdano: (2024-12-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
od: B N Shiva Prasad
Izdano: (2022-01-01)

Granulomatous Prostatitis Associated with Intravesical Bacillus Calmette Guerin Therapy
od: Elif Gündoğdu
Izdano: (2024-02-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
od: Sarah Hamdy Soliman, et al.
Izdano: (2023-01-01)

Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
od: Ugo Fedeli, et al.
Izdano: (2021-02-01)

Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases
od: Muhammad Umair Ijaz, et al.
Izdano: (2023-06-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
od: Maria Carolina Sisco, et al.
Izdano: (2020-05-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
od: Renata Monteiro-Maia, et al.
Izdano: (2014-09-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
od: Patricia Méndez-Samperio
Izdano: (2019-06-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
od: Yanin Chavarri-Guerra, et al.
Izdano: (2019-12-01)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
od: Suleiman Al-Hammadi, et al.
Izdano: (2017-05-01)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
od: Fernando Korkes, et al.
Izdano: (2021-02-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
od: Badria Al Waili, et al.
Izdano: (2021-02-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
od: Saeed Arasteh, et al.
Izdano: (2007-02-01)

Bacillus Calmette-Guérin Adenitis: An Intriguing Series of Four Cases
od: Meghadipa Mandal, et al.
Izdano: (2024-01-01)

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
od: Esther J.M. Taks, et al.
Izdano: (2023-11-01)

The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
od: Konstantin Föhse, et al.
Izdano: (2023-02-01)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
od: Masashi Miyazaki, et al.
Izdano: (2016-01-01)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
od: Sara Feola, et al.
Izdano: (2021-07-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
od: Sayed Ab. Reshad Ghafouri, et al.
Izdano: (2018-01-01)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
od: Junli Li, et al.
Izdano: (2021-01-01)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
od: Junli Li, et al.
Izdano: (2022-07-01)

Lectinhistochemical staining of granuloma induced by bacillus Calmette-Guerin in Piaractus mesopotamicus
od: Wilson G. Manrique, et al.
Izdano: (2013-11-01)

Endovascular repair of a bacillus Calmette-Guérin mycotic aortic aneurysm
od: Nader Tehrani, MD, et al.
Izdano: (2022-12-01)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
od: Mitchell V. Palmer, et al.
Izdano: (2018-10-01)